These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14692814)

  • 1. Survivin and Bcl-2 expression in prostatic adenocarcinomas.
    Kaur P; Kallakury BS; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
    Arch Pathol Lab Med; 2004 Jan; 128(1):39-43. PubMed ID: 14692814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
    Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence.
    Ross JS; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Stringer B
    Clin Cancer Res; 2004 Apr; 10(7):2466-72. PubMed ID: 15073126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer.
    Ross JS; Kaur P; Sheehan CE; Fisher HA; Kaufman RA; Kallakury BV
    Mod Pathol; 2003 Mar; 16(3):198-205. PubMed ID: 12640098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
    Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
    Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.
    Qiao JG; Zhang YQ; Yin YC; Tan Z
    World J Gastroenterol; 2004 Sep; 10(18):2759-61. PubMed ID: 15309737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.
    Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
    Hum Pathol; 2007 Apr; 38(4):564-9. PubMed ID: 17306334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.
    Nassar A; Sexton D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
    Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma.
    Sarela AI; Verbeke CS; Ramsdale J; Davies CL; Markham AF; Guillou PJ
    Br J Cancer; 2002 Mar; 86(6):886-92. PubMed ID: 11953819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF4 expression and apoptosis-related markers in gastric cancer.
    Krstic M; Stojnev S; Jovanovic L; Marjanovic G
    J BUON; 2013; 18(3):695-702. PubMed ID: 24065485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms.
    Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D
    Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression in colorectal adenocarcinoma using tissue microarray.
    Abd El-Hameed A
    J Egypt Natl Canc Inst; 2005 Mar; 17(1):42-50. PubMed ID: 16353082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.
    Sagol O; Yavuzsen T; Oztop I; Ulukus C; Ylmaz U; Alakavuklar M; Karademir S; Obuz F; Astarcoğlu H; Astarcoglu I
    Pancreas; 2005 May; 30(4):343-8. PubMed ID: 15841045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
    Amirghofran Z; Monabati A; Gholijani N
    Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.